|
|
Article: Reliant Pharmaceuticals to Launch Axid(R) Oral Solution.
- Article from:
- PR Newswire
- Article date:
- July 26, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LIBERTY CORNER, N.J., July 26 /PRNewswire/ -- Reliant Pharmaceuticals, Inc. today announced the introduction and the availability of Axid(R) (nizatidine) Oral Solution, a liquid formulation of the company's Axid capsules. Approved by the FDA in May of this year, Axid Oral Solution is indicated for use in pediatric patients age 12 and older for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to gastroesophageal reflux disease (GERD) for up to 12 weeks. In adults, Axid Oral Solution is also approved for the treatment of active duodenal ulcers.
"We are delighted to introduce this ...